General Information of Drug (ID: DM08UA2)

Drug Name
GSK3528869A
Indication
Disease Entry ICD 11 Status REF
Hepatitis B virus infection 1E51.0 Phase 1 [1]
Drug Type
Vaccine
Cross-matching ID
TTD ID
DJNY65

References

1 ClinicalTrials.gov (NCT03866187) A Study to Evaluate the Reactogenicity, Safety, Immunogenicity and Efficacy of GlaxoSmithKline (GSK) Biologicals' HBV (Hepatitis B Virus) Viral Vector Vaccines and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection.. U.S. National Institutes of Health.